Mefloquine Prophylaxis in HIV-1 Individuals: a Randomized Placebo-controlled Trial
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
This is a randomized placebo controlled trial. Malaria chemoprophylaxis with mefloquine in
asymptomatic HIV-infected adults living in a malaria endemic region of Luanshya, Zambia will
be compared to a placebo control group and followed up for 18 months.